Andreas Laubrock

Title: Andreas Laubrock: Innovator in RNA Labelling Technology

Introduction

Andreas Laubrock is a notable inventor based in Kiel, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of RNA labelling. His innovative work has implications for various applications in research and diagnostics.

Latest Patents

Andreas Laubrock holds a patent for a process titled "3'-RNA labelling with terminal transferase." This invention concerns a method for introducing non-radioactively labelled deoxynucleotides into nucleic acids and RNA molecules. The process specifically targets RNA molecules that contain at least one deoxynucleotide with a non-radioactive marker group at their 3' end. This advancement enhances the ability to label RNA without the use of radioactive materials, making it safer and more efficient for laboratory use.

Career Highlights

Andreas Laubrock is associated with Boehringer Mannheim GmbH, a company known for its contributions to biotechnology and pharmaceuticals. His work at the company has allowed him to focus on innovative solutions in molecular biology. With a patent portfolio that includes 1 patent, he continues to push the boundaries of scientific research.

Collaborations

Throughout his career, Andreas has collaborated with esteemed colleagues such as Viola Rosemeyer and Rudolf Seibl. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Andreas Laubrock's contributions to RNA labelling technology exemplify the impact of innovation in molecular biology. His work not only advances scientific understanding but also enhances practical applications in research and diagnostics.